皇冠新现金网平台：UCB to acquire Schwarz in �.4bncashandsharesdeal

UCB, the Belgian drug maker, was yesterday the latest company to join in the rash of mergers among Europe’s medium-sized pharmaceutical groups, with an agreed �.4bn ($5.6bn) cash and share offer for Schwarz Pharma.

比『利』时‘制药’商UCB【昨】日（与Schwarz Pharma达）成‘协’议， 欧‘元（’合56‘亿’美元）现 金[加]股票的出 价收「购」后（者，）令UCB「成为最」新『一』家加入『欧』洲中型制【药集】团 并[购]浪 潮〖的〗企『业。

Allbet代理

欢迎进入Allbet代理（Allbet Game）：www.aLLbetgame.us，欧博官网是欧博集团的官方网站。欧博官网开放Allbet注册、Allbe代理、Allbet电脑客户端、Allbet手机版下载等业务。

The deal, the third of its kind in almost as many days, will create a company with annual turnover of more than �.3bn and increase the number of late-stage products at UCB.

这』是克日第『三宗』并（购）交‘易。’此笔生意营业将“缔”造一家{年}营{业}额〖凌驾33〗亿《欧元的》制《药》企 同时将增「加UCB」开「发末」期产物「的」